- For the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy
Coverage of drugs is first determined by the memberís pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document.
|Drug||Dosing Regimen||Dose Limit/ Maximum Dose|
|This field intentionally left blank||This field intentionally left blank||This field intentionally left blank|
|Drug||Dosing Regimen||Authorization Limit|
This section intentionally left blank